ARCH Venture Partners XII, LLC's Net Worth

$0

Estimate Recalculated Nov 8, 2024 04:41PM EST

Who is ARCH Venture Partners XII, LLC?

ARCH Venture Partners XII, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Neumora Therapeutics, Inc., Prime Medicine, Inc., and Rapport Therapeutics, Inc..

SEC CIK

ARCH Venture Partners XII, LLC's CIK is 0001979548

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Neumora Therapeutics, Inc. (NMRA) Snapshot price: $10.46

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+102.76%
1.88M
—
—
3.71M
Dec 8
Form 4
+0.85%
35.01K
$11.77
$412,139.61
4.13M
Nov 13 - Nov 14
Form 4
+3.55%
140.6K
$10.98
$1,543,563.42
4.1M
Nov 8 - Nov 10
Form 4
+2.48%
95.69K
$11.49
$1,099,944.70
3.96M
Nov 3 - Nov 7
Form 4
+2.02%
76.51K
$13.68
$1,046,848.16
3.86M
Sep 28 - Sep 29
Form 4
+1.57%
58.5K
$11.97
$700,464.24
3.78M
Sep 26 - Sep 27
Form 4
+2.78%
100.74K
$11.19
$1,127,063.95
3.72M
Sep 22 - Sep 25
Form 4
+178.19%
18.92M
$17.00
—
29.55M
Sep 19
Form 3
—
0
—
—
0
No matching records found

Rapport Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.73M
—
—
3.73M
Jun 10
Form 3
—
0
—
—
0
No matching records found

Prime Medicine, Inc. (PRME) Snapshot price: $3.4303

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.2M
$6.25
$20,000,000.00
3.2M
Feb 15
No matching records found